DividendInvestor.com

First In Dividend Data Worldwide®

DIVIDEND ANNOUNCEMENT: Ord Cl A/Royalty Pharma plc (NASDAQ:RPRX) on 07/16/2021 declared a dividend of $0.1700 per share

July 16, 2021

Ord Cl A/Royalty Pharma plc (NASDAQ:RPRX) on 07/16/2021 declared a dividend of $ 0.1700 per share payable on September 15, 2021 to shareholders of record as of August 20, 2021.

Ord Cl A/Royalty Pharma plc (NASDAQ:RPRX) has paid dividends since 1970, has a current dividend yield of 1.6217563152% and has increased its dividends for 0 successive years.

Ord Cl A/Royalty Pharma plc's market cap is $ 15,745,708,560 and has a PE ratio of 26.72. The stock price closed yesterday at $ 40.08 and has a 52 week low/high of $ 34.80 and $ 53.23.

Royalty Pharma is a funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Co.'s portfolio includes royalties on more than 45 commercial products, including AbbVie and J&J's Imbruvica, Astellas and Pfizer's Xtandi, Biogen's Tysabri, Gilead's HIV franchise, Merck's Januvia, Novartis' Promacta, and Vertex's Kalydeco, Symdeko and Trikafta, and three development-stage product candidates.

For more information on Ord Cl A/Royalty Pharma plc click here.

Ord Cl A/Royalty Pharma plc current dividend information as per the date of this press release is:
Dividend Declaration Date: July 16, 2021
Dividend Ex Date: August 19, 2021
Dividend Record Date: August 20, 2021
Dividend Payment Date: September 15, 2021
Dividend Amount: $ 0.1700
 
 

DividendInvestor.com

DividendInvestor.com is a leading worldwide independent provider of dividend information and data for investment professionals. Our mission is to be the First In Dividend Data Worldwide® by designing and developing essential tools and systems for the investment community with the highest level of accuracy and integrity.

Contact:
info@DividendInvestor.com

X
Search Dividend Investor